search
Back to results

Sleep, Cognition and Memory Disorder (SCOAL)

Primary Purpose

Sleep Architecture, Sleep Disorders, Cognitive Impairment

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
2 night polysomnography
battery of neuropsychological tests
virtual reality test
subjective evaluation of sleep and somnolence
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Sleep Architecture focused on measuring Alzheimer, Sleep, Somnolence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria for patients with mild cognitive impairment included in MEMENTO cohort:

  • Aged 18 years and above
  • included in MEMENTO cohort within the last 3 months
  • Clinical dementia rating scale ≤ 0,5 (not demented)
  • Patients with mild cognitive impairment
  • Visual and auditory acuity adequate for neuropsychological testing
  • Having signed an informed consent
  • Being affiliated to health insurance

Inclusion criteria for patients with mild cognitive impairment not included in MEMENTO cohort:

  • Aged 18 years and above
  • First contact with Memory clinic within the last 3 months
  • Clinical dementia rating scale ≤ 0,5 (not demented)
  • Patients with mild cognitive impairment
  • Visual and auditory acuity adequate for neuropsychological testing
  • Having signed an informed consent
  • Being affiliated to health insurance

Inclusion criteria for Healthy volunteers and Control group:

  • Aged 18 years and above
  • Without evidence of psychopathology
  • Volunteers matched in age, sex and educational level with patients
  • Visual and auditory acuity adequate for neuropsychological testing
  • Having signed an informed consent
  • Being affiliated to health insurance

Exclusion criteria:

  • Being under guardian conservator
  • Residence in skilled nursing facility
  • Pregnant or breast feeding woman
  • Alzheimer's disease caused by gene mutations
  • Having a neurological disease
  • History of stroke within the past three months
  • Generalized anxiety (DSM-IV criteria)
  • Schizophrenia history (DSM-IV criteria)
  • Illiteracy, is unable to count or to read

Sites / Locations

  • CHU de Bordeaux

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Active Comparator

Active Comparator

Arm Label

Patients from Memento cohort.

Patients with memory disorders

Healthy volunteers

control group

Arm Description

Patients with mild cognitive impairment included in MEMENTO cohort. These patients will have a 2 night polysomnography, a battery of neuropsychological tests, a virtual reality test, and a subjective evaluation of sleep and somnolence at inclusion (Month 0) and Month 12.

Patients with mild cognitive impairment not included in MEMENTO cohort. For these patients a virtual reality test, and a subjective evaluation of sleep and somnolence will be performed at Inclusion (Month 0)

Healthy volunteers matched in age, sex and educational level with patients. For these volunteers a virtual reality test, and a subjective evaluation of sleep and somnolence will be performed at Inclusion (Month 0)

this group is composed with Healthy volunteers these volunteers will have a 2 night polysomnography, a battery of neuropsychological tests, a virtual reality test, and a subjective evaluation of sleep and somnolence at inclusion (Month 0) and Month 12.

Outcomes

Primary Outcome Measures

Polysomnography of night 1
- Apnea/Hypopnea index, periodic limb movements index
Polysomnography of night 1
- Excessive transient muscle activity, Sustained muscle activity
Polysomnography of night 1
- Sleep structure parameters (% stage 1, 2, 3 and Rapid Eye movement, Delta activity, Spindle rate)
Polysomnography of night 1
- Sleep duration parameters
Polysomnography of night 1
- Sleep consolidation parameters
Polysomnography of night 1
- Sleep propensity parameters 24-hour melatonin quantity rate
Polysomnography of night 1
Actimetry: Inter-daily stability, intra-daily variability, rhythm amplitude

Secondary Outcome Measures

Subjective evaluation of sleep and Somnolence
Evaluation of Memory disorder
Reaction times and % of errors in the neuropsychological tests (memory, speed processing, language, visuo-spatial skills, attentional functions, executive functions)
Evaluation of Memory disorder
% of recall from the memory test in a virtual environment

Full Information

First Posted
July 18, 2012
Last Updated
June 29, 2021
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT01650454
Brief Title
Sleep, Cognition and Memory Disorder
Acronym
SCOAL
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
October 29, 2015 (Actual)
Study Completion Date
October 29, 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The increasing incidence of Alzheimer's disease (AD) and related sleep-disorders with the aging of the population is a major issue of public health. The prevalence of sleep disturbances is about 50% in dementia patients. Sleep in dementia is mainly characterized by prolonged night-time awakenings, sometimes with longer sleep latency and/or early awakening. The presence of these sleep disturbances is the main reason for the institutionalization of AD patients, as well as a major cause of the deterioration of the caregivers' sleep. The MEMENTO cohort is composed of patients with isolated memory complaints or mild cognitive impairment, at high risk to develop dementia. All voluntary patients from the CMRR (Center of Memory, resources and Research) of Bordeaux (MEMENTO cohort) will be tested at inclusion and followed-up 1 year later. For these two evaluations, actigraphic monitoring at home, 2-night polysomnography (PSG) monitoring at hospital including a 24-hour period of urinary melatonin dosage, neuropsychological tests battery, a virtual reality tool and questionnaires will be used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Architecture, Sleep Disorders, Cognitive Impairment
Keywords
Alzheimer, Sleep, Somnolence

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
58 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients from Memento cohort.
Arm Type
Experimental
Arm Description
Patients with mild cognitive impairment included in MEMENTO cohort. These patients will have a 2 night polysomnography, a battery of neuropsychological tests, a virtual reality test, and a subjective evaluation of sleep and somnolence at inclusion (Month 0) and Month 12.
Arm Title
Patients with memory disorders
Arm Type
Experimental
Arm Description
Patients with mild cognitive impairment not included in MEMENTO cohort. For these patients a virtual reality test, and a subjective evaluation of sleep and somnolence will be performed at Inclusion (Month 0)
Arm Title
Healthy volunteers
Arm Type
Active Comparator
Arm Description
Healthy volunteers matched in age, sex and educational level with patients. For these volunteers a virtual reality test, and a subjective evaluation of sleep and somnolence will be performed at Inclusion (Month 0)
Arm Title
control group
Arm Type
Active Comparator
Arm Description
this group is composed with Healthy volunteers these volunteers will have a 2 night polysomnography, a battery of neuropsychological tests, a virtual reality test, and a subjective evaluation of sleep and somnolence at inclusion (Month 0) and Month 12.
Intervention Type
Other
Intervention Name(s)
2 night polysomnography
Intervention Description
Polysomnography
Intervention Type
Other
Intervention Name(s)
battery of neuropsychological tests
Intervention Type
Other
Intervention Name(s)
virtual reality test
Intervention Type
Other
Intervention Name(s)
subjective evaluation of sleep and somnolence
Primary Outcome Measure Information:
Title
Polysomnography of night 1
Description
- Apnea/Hypopnea index, periodic limb movements index
Time Frame
Change from inclusion (Month 0) and Month 12
Title
Polysomnography of night 1
Description
- Excessive transient muscle activity, Sustained muscle activity
Time Frame
Change from inclusion (Month 0) and Month 12
Title
Polysomnography of night 1
Description
- Sleep structure parameters (% stage 1, 2, 3 and Rapid Eye movement, Delta activity, Spindle rate)
Time Frame
Change from inclusion (Month 0) and Month 12
Title
Polysomnography of night 1
Description
- Sleep duration parameters
Time Frame
Change from inclusion (Month 0) and Month 12
Title
Polysomnography of night 1
Description
- Sleep consolidation parameters
Time Frame
Change from inclusion (Month 0) and Month 12
Title
Polysomnography of night 1
Description
- Sleep propensity parameters 24-hour melatonin quantity rate
Time Frame
Change from inclusion (Month 0) and Month 12
Title
Polysomnography of night 1
Description
Actimetry: Inter-daily stability, intra-daily variability, rhythm amplitude
Time Frame
Change from inclusion (Month 0) and Month 12
Secondary Outcome Measure Information:
Title
Subjective evaluation of sleep and Somnolence
Time Frame
Month 0 and Month 12
Title
Evaluation of Memory disorder
Description
Reaction times and % of errors in the neuropsychological tests (memory, speed processing, language, visuo-spatial skills, attentional functions, executive functions)
Time Frame
Month 0 and Month12
Title
Evaluation of Memory disorder
Description
% of recall from the memory test in a virtual environment
Time Frame
Month 0 and Month12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria for patients with mild cognitive impairment included in MEMENTO cohort: Aged 18 years and above included in MEMENTO cohort within the last 3 months Clinical dementia rating scale ≤ 0,5 (not demented) Patients with mild cognitive impairment Visual and auditory acuity adequate for neuropsychological testing Having signed an informed consent Being affiliated to health insurance Inclusion criteria for patients with mild cognitive impairment not included in MEMENTO cohort: Aged 18 years and above First contact with Memory clinic within the last 3 months Clinical dementia rating scale ≤ 0,5 (not demented) Patients with mild cognitive impairment Visual and auditory acuity adequate for neuropsychological testing Having signed an informed consent Being affiliated to health insurance Inclusion criteria for Healthy volunteers and Control group: Aged 18 years and above Without evidence of psychopathology Volunteers matched in age, sex and educational level with patients Visual and auditory acuity adequate for neuropsychological testing Having signed an informed consent Being affiliated to health insurance Exclusion criteria: Being under guardian conservator Residence in skilled nursing facility Pregnant or breast feeding woman Alzheimer's disease caused by gene mutations Having a neurological disease History of stroke within the past three months Generalized anxiety (DSM-IV criteria) Schizophrenia history (DSM-IV criteria) Illiteracy, is unable to count or to read
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre Philip, Pr
Organizational Affiliation
CHU Bordeaux
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Bordeaux
City
Bordeaux
ZIP/Postal Code
33076
Country
France

12. IPD Sharing Statement

Learn more about this trial

Sleep, Cognition and Memory Disorder

We'll reach out to this number within 24 hrs